Importance of urine drug testing in the treatment of chronic noncancer pain: implications of recent medicare policy changes in kentucky

Urine drug testing has become a widely used tool in American society for deterring illicit drug use. In the practice of medicine, urine drug testing is commonly used to help diagnose substance misuse, abuse, or addiction. This narrative review provides an informed perspective on the importance of ur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pain physician 2010-03, Vol.13 (2), p.167-186
Hauptverfasser: Gilbert, John W, Wheeler, G R, Mick, G E, Storey, B B, Herder, S L, Richardson, G B, Watts, E, Gyarteng-Dakwa, K, Marino, B S, Kenney, C M, Siddiqi, M, Broughton, P G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 186
container_issue 2
container_start_page 167
container_title Pain physician
container_volume 13
creator Gilbert, John W
Wheeler, G R
Mick, G E
Storey, B B
Herder, S L
Richardson, G B
Watts, E
Gyarteng-Dakwa, K
Marino, B S
Kenney, C M
Siddiqi, M
Broughton, P G
description Urine drug testing has become a widely used tool in American society for deterring illicit drug use. In the practice of medicine, urine drug testing is commonly used to help diagnose substance misuse, abuse, or addiction. This narrative review provides an informed perspective on the importance of urine drug testing in the medical treatment of chronic noncancer pain. The history and current uses of urine drug tests in the United States are reviewed, the prevalence and nature of prescription drug misuse is described as is related to chronic noncancer pain, and implications and considerations for practitioners are presented related to the noncancer pain diagnosis and treatment. Practitioners are confronted with the ethical and legal dilemma of being called to adequately treat chronic pain in a culture with a high prevalence of prescription drug abuse. Yet the symptoms of drug abuse are nonspecific and therefore of limited value to the practitioner in determining patient compliance to drug treatment regimens. In contrast, urine drug testing has a reliable history, both in and out of medicine, as an independent sign of drug misuse. This sign can be used to aid in the diagnosis and treatment of drug misuse and underlying addictions to improve patient outcomes. Regular urine drug testing should be a part of acute and chronic pain management whether or not the patient has any signs or symptoms of drug misuse.
doi_str_mv 10.36076/ppj.2010/13/167
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733563619</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733563619</sourcerecordid><originalsourceid>FETCH-LOGICAL-c321t-d4bc92671a2fa58dda2e4357be180eaa9ef14fe7f752ea5ad84956e8fb19668d3</originalsourceid><addsrcrecordid>eNpdkb1uHCEURpEVK9446V1FSClSjRe4AzOki6z8WLKUJqkRy9xZs96BCTDFPoFf20zspEiFxD3fJ7iHkCvOrkGxTm3n-XAtGGdbDluuujOyEVyyhvNWvyIbLgEa4FJfkDc5HxgDpTW8JheCAdPQw4Y83k5zTMUGhzSOdEk-IB3SsqcFc_FhT32g5R5pSWjLhKGsmLtPMXhHQwxujSY6Wx8-UT_NR-9s8THklUvo1sSEQ71NSOdYx6cat2GPea1-qPPFPZzekvPRHjO-ezkvya-vX37efG_ufny7vfl81zgQvDRDu3NaqI5bMVrZD4MV2ILsdsh7htZqHHk7Yjd2UqCVduhbLRX2445rpfoBLsnH5945xd9L_aKZfHZ4PNqAccmmA5AKFNeV_PAfeYhLCvVxRigp6yLbrq8Ue6ZcijknHM2c_GTTyXBm_jgy1ZFZHRkOpjqqkfcvxcuubuZf4K8UeAKCGI_q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2655993478</pqid></control><display><type>article</type><title>Importance of urine drug testing in the treatment of chronic noncancer pain: implications of recent medicare policy changes in kentucky</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Gilbert, John W ; Wheeler, G R ; Mick, G E ; Storey, B B ; Herder, S L ; Richardson, G B ; Watts, E ; Gyarteng-Dakwa, K ; Marino, B S ; Kenney, C M ; Siddiqi, M ; Broughton, P G</creator><creatorcontrib>Gilbert, John W ; Wheeler, G R ; Mick, G E ; Storey, B B ; Herder, S L ; Richardson, G B ; Watts, E ; Gyarteng-Dakwa, K ; Marino, B S ; Kenney, C M ; Siddiqi, M ; Broughton, P G</creatorcontrib><description>Urine drug testing has become a widely used tool in American society for deterring illicit drug use. In the practice of medicine, urine drug testing is commonly used to help diagnose substance misuse, abuse, or addiction. This narrative review provides an informed perspective on the importance of urine drug testing in the medical treatment of chronic noncancer pain. The history and current uses of urine drug tests in the United States are reviewed, the prevalence and nature of prescription drug misuse is described as is related to chronic noncancer pain, and implications and considerations for practitioners are presented related to the noncancer pain diagnosis and treatment. Practitioners are confronted with the ethical and legal dilemma of being called to adequately treat chronic pain in a culture with a high prevalence of prescription drug abuse. Yet the symptoms of drug abuse are nonspecific and therefore of limited value to the practitioner in determining patient compliance to drug treatment regimens. In contrast, urine drug testing has a reliable history, both in and out of medicine, as an independent sign of drug misuse. This sign can be used to aid in the diagnosis and treatment of drug misuse and underlying addictions to improve patient outcomes. Regular urine drug testing should be a part of acute and chronic pain management whether or not the patient has any signs or symptoms of drug misuse.</description><identifier>ISSN: 1533-3159</identifier><identifier>EISSN: 2150-1149</identifier><identifier>DOI: 10.36076/ppj.2010/13/167</identifier><identifier>PMID: 20309383</identifier><language>eng</language><publisher>United States: American Society of Interventional Pain Physician</publisher><subject>Drug abuse ; Drug testing ; History, 20th Century ; Humans ; Kentucky ; Legislation, Drug - trends ; Medical diagnosis ; Medicare - trends ; Opioid-Related Disorders - diagnosis ; Opioid-Related Disorders - prevention &amp; control ; Opioid-Related Disorders - urine ; Pain ; Pain, Intractable - drug therapy ; Pain, Intractable - prevention &amp; control ; Practice Patterns, Physicians' - legislation &amp; jurisprudence ; Practice Patterns, Physicians' - standards ; Practice Patterns, Physicians' - trends ; Prescription drugs ; Prescriptions - standards ; Substance Abuse Detection - history ; Substance Abuse Detection - legislation &amp; jurisprudence ; Substance Abuse Detection - standards ; Substance abuse treatment ; United States ; Urinalysis - history ; Urinalysis - standards ; Urine</subject><ispartof>Pain physician, 2010-03, Vol.13 (2), p.167-186</ispartof><rights>2010. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20309383$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gilbert, John W</creatorcontrib><creatorcontrib>Wheeler, G R</creatorcontrib><creatorcontrib>Mick, G E</creatorcontrib><creatorcontrib>Storey, B B</creatorcontrib><creatorcontrib>Herder, S L</creatorcontrib><creatorcontrib>Richardson, G B</creatorcontrib><creatorcontrib>Watts, E</creatorcontrib><creatorcontrib>Gyarteng-Dakwa, K</creatorcontrib><creatorcontrib>Marino, B S</creatorcontrib><creatorcontrib>Kenney, C M</creatorcontrib><creatorcontrib>Siddiqi, M</creatorcontrib><creatorcontrib>Broughton, P G</creatorcontrib><title>Importance of urine drug testing in the treatment of chronic noncancer pain: implications of recent medicare policy changes in kentucky</title><title>Pain physician</title><addtitle>Pain Physician</addtitle><description>Urine drug testing has become a widely used tool in American society for deterring illicit drug use. In the practice of medicine, urine drug testing is commonly used to help diagnose substance misuse, abuse, or addiction. This narrative review provides an informed perspective on the importance of urine drug testing in the medical treatment of chronic noncancer pain. The history and current uses of urine drug tests in the United States are reviewed, the prevalence and nature of prescription drug misuse is described as is related to chronic noncancer pain, and implications and considerations for practitioners are presented related to the noncancer pain diagnosis and treatment. Practitioners are confronted with the ethical and legal dilemma of being called to adequately treat chronic pain in a culture with a high prevalence of prescription drug abuse. Yet the symptoms of drug abuse are nonspecific and therefore of limited value to the practitioner in determining patient compliance to drug treatment regimens. In contrast, urine drug testing has a reliable history, both in and out of medicine, as an independent sign of drug misuse. This sign can be used to aid in the diagnosis and treatment of drug misuse and underlying addictions to improve patient outcomes. Regular urine drug testing should be a part of acute and chronic pain management whether or not the patient has any signs or symptoms of drug misuse.</description><subject>Drug abuse</subject><subject>Drug testing</subject><subject>History, 20th Century</subject><subject>Humans</subject><subject>Kentucky</subject><subject>Legislation, Drug - trends</subject><subject>Medical diagnosis</subject><subject>Medicare - trends</subject><subject>Opioid-Related Disorders - diagnosis</subject><subject>Opioid-Related Disorders - prevention &amp; control</subject><subject>Opioid-Related Disorders - urine</subject><subject>Pain</subject><subject>Pain, Intractable - drug therapy</subject><subject>Pain, Intractable - prevention &amp; control</subject><subject>Practice Patterns, Physicians' - legislation &amp; jurisprudence</subject><subject>Practice Patterns, Physicians' - standards</subject><subject>Practice Patterns, Physicians' - trends</subject><subject>Prescription drugs</subject><subject>Prescriptions - standards</subject><subject>Substance Abuse Detection - history</subject><subject>Substance Abuse Detection - legislation &amp; jurisprudence</subject><subject>Substance Abuse Detection - standards</subject><subject>Substance abuse treatment</subject><subject>United States</subject><subject>Urinalysis - history</subject><subject>Urinalysis - standards</subject><subject>Urine</subject><issn>1533-3159</issn><issn>2150-1149</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkb1uHCEURpEVK9446V1FSClSjRe4AzOki6z8WLKUJqkRy9xZs96BCTDFPoFf20zspEiFxD3fJ7iHkCvOrkGxTm3n-XAtGGdbDluuujOyEVyyhvNWvyIbLgEa4FJfkDc5HxgDpTW8JheCAdPQw4Y83k5zTMUGhzSOdEk-IB3SsqcFc_FhT32g5R5pSWjLhKGsmLtPMXhHQwxujSY6Wx8-UT_NR-9s8THklUvo1sSEQ71NSOdYx6cat2GPea1-qPPFPZzekvPRHjO-ezkvya-vX37efG_ufny7vfl81zgQvDRDu3NaqI5bMVrZD4MV2ILsdsh7htZqHHk7Yjd2UqCVduhbLRX2445rpfoBLsnH5945xd9L_aKZfHZ4PNqAccmmA5AKFNeV_PAfeYhLCvVxRigp6yLbrq8Ue6ZcijknHM2c_GTTyXBm_jgy1ZFZHRkOpjqqkfcvxcuubuZf4K8UeAKCGI_q</recordid><startdate>20100301</startdate><enddate>20100301</enddate><creator>Gilbert, John W</creator><creator>Wheeler, G R</creator><creator>Mick, G E</creator><creator>Storey, B B</creator><creator>Herder, S L</creator><creator>Richardson, G B</creator><creator>Watts, E</creator><creator>Gyarteng-Dakwa, K</creator><creator>Marino, B S</creator><creator>Kenney, C M</creator><creator>Siddiqi, M</creator><creator>Broughton, P G</creator><general>American Society of Interventional Pain Physician</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20100301</creationdate><title>Importance of urine drug testing in the treatment of chronic noncancer pain: implications of recent medicare policy changes in kentucky</title><author>Gilbert, John W ; Wheeler, G R ; Mick, G E ; Storey, B B ; Herder, S L ; Richardson, G B ; Watts, E ; Gyarteng-Dakwa, K ; Marino, B S ; Kenney, C M ; Siddiqi, M ; Broughton, P G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c321t-d4bc92671a2fa58dda2e4357be180eaa9ef14fe7f752ea5ad84956e8fb19668d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Drug abuse</topic><topic>Drug testing</topic><topic>History, 20th Century</topic><topic>Humans</topic><topic>Kentucky</topic><topic>Legislation, Drug - trends</topic><topic>Medical diagnosis</topic><topic>Medicare - trends</topic><topic>Opioid-Related Disorders - diagnosis</topic><topic>Opioid-Related Disorders - prevention &amp; control</topic><topic>Opioid-Related Disorders - urine</topic><topic>Pain</topic><topic>Pain, Intractable - drug therapy</topic><topic>Pain, Intractable - prevention &amp; control</topic><topic>Practice Patterns, Physicians' - legislation &amp; jurisprudence</topic><topic>Practice Patterns, Physicians' - standards</topic><topic>Practice Patterns, Physicians' - trends</topic><topic>Prescription drugs</topic><topic>Prescriptions - standards</topic><topic>Substance Abuse Detection - history</topic><topic>Substance Abuse Detection - legislation &amp; jurisprudence</topic><topic>Substance Abuse Detection - standards</topic><topic>Substance abuse treatment</topic><topic>United States</topic><topic>Urinalysis - history</topic><topic>Urinalysis - standards</topic><topic>Urine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gilbert, John W</creatorcontrib><creatorcontrib>Wheeler, G R</creatorcontrib><creatorcontrib>Mick, G E</creatorcontrib><creatorcontrib>Storey, B B</creatorcontrib><creatorcontrib>Herder, S L</creatorcontrib><creatorcontrib>Richardson, G B</creatorcontrib><creatorcontrib>Watts, E</creatorcontrib><creatorcontrib>Gyarteng-Dakwa, K</creatorcontrib><creatorcontrib>Marino, B S</creatorcontrib><creatorcontrib>Kenney, C M</creatorcontrib><creatorcontrib>Siddiqi, M</creatorcontrib><creatorcontrib>Broughton, P G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Pain physician</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gilbert, John W</au><au>Wheeler, G R</au><au>Mick, G E</au><au>Storey, B B</au><au>Herder, S L</au><au>Richardson, G B</au><au>Watts, E</au><au>Gyarteng-Dakwa, K</au><au>Marino, B S</au><au>Kenney, C M</au><au>Siddiqi, M</au><au>Broughton, P G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Importance of urine drug testing in the treatment of chronic noncancer pain: implications of recent medicare policy changes in kentucky</atitle><jtitle>Pain physician</jtitle><addtitle>Pain Physician</addtitle><date>2010-03-01</date><risdate>2010</risdate><volume>13</volume><issue>2</issue><spage>167</spage><epage>186</epage><pages>167-186</pages><issn>1533-3159</issn><eissn>2150-1149</eissn><abstract>Urine drug testing has become a widely used tool in American society for deterring illicit drug use. In the practice of medicine, urine drug testing is commonly used to help diagnose substance misuse, abuse, or addiction. This narrative review provides an informed perspective on the importance of urine drug testing in the medical treatment of chronic noncancer pain. The history and current uses of urine drug tests in the United States are reviewed, the prevalence and nature of prescription drug misuse is described as is related to chronic noncancer pain, and implications and considerations for practitioners are presented related to the noncancer pain diagnosis and treatment. Practitioners are confronted with the ethical and legal dilemma of being called to adequately treat chronic pain in a culture with a high prevalence of prescription drug abuse. Yet the symptoms of drug abuse are nonspecific and therefore of limited value to the practitioner in determining patient compliance to drug treatment regimens. In contrast, urine drug testing has a reliable history, both in and out of medicine, as an independent sign of drug misuse. This sign can be used to aid in the diagnosis and treatment of drug misuse and underlying addictions to improve patient outcomes. Regular urine drug testing should be a part of acute and chronic pain management whether or not the patient has any signs or symptoms of drug misuse.</abstract><cop>United States</cop><pub>American Society of Interventional Pain Physician</pub><pmid>20309383</pmid><doi>10.36076/ppj.2010/13/167</doi><tpages>20</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1533-3159
ispartof Pain physician, 2010-03, Vol.13 (2), p.167-186
issn 1533-3159
2150-1149
language eng
recordid cdi_proquest_miscellaneous_733563619
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Drug abuse
Drug testing
History, 20th Century
Humans
Kentucky
Legislation, Drug - trends
Medical diagnosis
Medicare - trends
Opioid-Related Disorders - diagnosis
Opioid-Related Disorders - prevention & control
Opioid-Related Disorders - urine
Pain
Pain, Intractable - drug therapy
Pain, Intractable - prevention & control
Practice Patterns, Physicians' - legislation & jurisprudence
Practice Patterns, Physicians' - standards
Practice Patterns, Physicians' - trends
Prescription drugs
Prescriptions - standards
Substance Abuse Detection - history
Substance Abuse Detection - legislation & jurisprudence
Substance Abuse Detection - standards
Substance abuse treatment
United States
Urinalysis - history
Urinalysis - standards
Urine
title Importance of urine drug testing in the treatment of chronic noncancer pain: implications of recent medicare policy changes in kentucky
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T15%3A03%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Importance%20of%20urine%20drug%20testing%20in%20the%20treatment%20of%20chronic%20noncancer%20pain:%20implications%20of%20recent%20medicare%20policy%20changes%20in%20kentucky&rft.jtitle=Pain%20physician&rft.au=Gilbert,%20John%20W&rft.date=2010-03-01&rft.volume=13&rft.issue=2&rft.spage=167&rft.epage=186&rft.pages=167-186&rft.issn=1533-3159&rft.eissn=2150-1149&rft_id=info:doi/10.36076/ppj.2010/13/167&rft_dat=%3Cproquest_cross%3E733563619%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2655993478&rft_id=info:pmid/20309383&rfr_iscdi=true